Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (3): 201-209.doi: 10.3736/jcim20100301

• Review •     Next Articles

Pathogenesis and treatment of non-alcoholic fatty liver disease

Ping Xie, Xin-xi Zhou, Qin Zhang   

  1. Department of Liver Diseases, Shanghai Public Clinical Health Center, Fudan University, Shanghai 201508, China
  • Received:2009-11-09 Accepted:2010-01-29 Online:2010-03-20 Published:2010-03-15
  • Contact: Qin Zhang E-mail:zhangqin@shaphc.org

In order to explore the pathogenesis of non-alcoholic fatty liver disease (NAFLD), and to find the best evidence for clinical practice, recent literature about the pathogenesis and treatment of NAFLD was analyzed, and it was found that the generation of reactive oxygen species (ROS) is the most important factor in development of NAFLD. Based on insulin resistance (IR), generation of ROS is a central link in the course of “two hits”. Other factors, such as leptin resistance, caspase-3, Fas and its ligand, peripheral natural killer T cells, cyclooxygenase-2, metabolic nuclear receptors, hepatic deposition of iron, ferritin, haptoglobin, retinol binding protein 4, imbalance of intestinal flora, mitochondrial dysfunction and endoplasmic reticulum stress, also contribute to the progress of NAFLD. In the treatment of NAFLD, beside the conventionally used methods such as IR improvement, antioxidation and lipid metabolism improvement, other medicines such as nuclear metabolism ligands or activators, iron-chelating agents and syndrome differentiation treatment in traditional Chinese medicine also have good efficacy.

Key words: Non-alcoholic fatty liver, Pathogenesis, Treatment

[1] Pan AQ . The role of insulin resistance and leptin in non-alcoholic fatty liver disease[J]. Zhongguo Yi Yao Dao Kan, 2008,10(3):400-401
潘爱群 . 胰岛素抵抗、瘦素在非酒精性脂肪肝发病中的作用[J]. 中国医药导刊, 2008,10(3):400-401
[2] Frayn KN . Visceral fat and insulin resistence: causative or correlative?[J]. Br J Nutr, 2000,83(Suppl 1):S71-S77
[3] Petta S, Camma C, Marco VD, Alessi N, Barbaria F, Cabibi D, Caldarella R, Ciminnisi S, Licata A, Massenti MF, Mazzola A, Tarantino G, Marchesini G, Crax A . Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with HCV genotype 1[J]. Hepatology, 2008,48(1):28-37
[4] Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB . Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes[J]. Nature, 2005,436(7049):356-362
doi: 10.1038/nature03711
[5] Shiota G . Loss of function of retinoic acid in liver leads to steatohepatitis and liver tumor: A NASH animal model[J]. Hepatol Res, 2005,33(2):155-160
doi: 10.1016/j.hepres.2005.09.025
[6] Maher JJ, Leon P, Ryan JC . Beyong insulin resistance: innate immunity in nonalcoholic steatohepatitis[J]. Hepatology, 2008,48(2):670-678
doi: 10.1002/hep.v48:2
[7] Ma X . Metabolic nuclear receptors: a new target for therapy of non-alcoholic fatty liver disease[J]. Guo Ji Xiao Hua Bing Za Zhi, 2008,28(2):91-93
马雄 . 代谢性核受体: 非酒精性脂肪性肝病治疗的新靶点[J]. 国际消化病杂志, 2008,28(2):91-93
[8] Lin J, Tarr PT, Yang R, Rhee J, Puigserver P, Newgard CB, Spiegelman BM . PGC-1beta in the regulation of hepatic glucose and energy metabolism[J]. J Biol Chem, 2003,278(33):30843-30848
doi: 10.1074/jbc.M303643200
[9] Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM . Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1[J]. Nature, 2001,413(6852):131-138
doi: 10.1038/35093050
[10] Pei Q, Wang XS, Wang XB . Study progress of pathogenesis of non-alcoholic steatohepatitis[J]. Lin Chuang Gan Dan Bing Za Zhi, 2008,24(4):304-306
裴强, 王晓素, 王宪波 . 非酒精性脂肪性肝炎发病机制的研究进展[J]. 临床肝胆病杂志, 2008,24(4):304-306
[11] Yu ZY, Gao P, Shen L, Huang HY, Dan J . Expression of endoplasmic reticulum molecular chaperone GRP94 in human nonalcoholic fatty liver and its clinical significance[J]. Shi Jie Hua Ren Xiao Hua Za Zhi, 2008,16(31):3566-3570
俞泽元, 高鹏, 申力, 黄海云, 但杰 . 内质网分子伴侣糖调节蛋白94在非酒精性脂肪肝中的表达及意义[J]. 世界华人消化杂志, 2008,16(31):3566-3570
[12] Ji C . Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury[J]. J Gastroenterol Hepatol, 2008,23(Suppl 1):S16-S24
doi: 10.1111/j.1440-1746.2007.05276.x
[13] Gu XH, Zhang YD, Feng AJ . Expression of uncoupling protein 2 in nonalcoholic fatty liver of rats[J]. Shi Jie Hua Ren Xiao Hua Za Zhi, 2005,13(19):2310-2313
顾小红, 张云东, 冯爱娟 . 解偶联蛋白-2在大鼠非酒精性脂肪肝中的表达[J]. 世界华人消化杂志, 2005,13(19):2310-2313
[14] Wang CH, Chen DF . The role of mitochondrial permeability transition pore in apoptosis of non-alcoholic fatty liver cells[J]. Chongqing Yi Xue, 2007,36(8):714-715
王春华, 陈东风 . 线粒体膜通透性转换孔在非酒精性脂肪肝细胞凋亡中的作用[J]. 重庆医学, 2007,36(8):714-715
[15] Nan YM, Qiao L, Yu J, Wu WJ, Yao XX . Fas and its ligand in inducing liver cell apoptosis of non-alcoholic steatohepatitis[J]. Zhonghua Xiao Hua Za Zhi, 2006,26(12):841-842
南月敏, 乔梁, 于君, 吴文娟, 姚希贤 . Fas及其配体诱导非酒精性脂肪性肝炎肝细胞凋亡[J]. 中华消化杂志, 2006,26(12):841-842
[16] Oh MK, Winn J, Poordad F . Review article: diagnosis and treatment of non-alcoholic fatty liver disease[J]. Aliment Pharmacol Ther, 2008,28(5):503-522
doi: 10.1111/apt.2008.28.issue-5
[17] Nelson JE, Bhattacharya R, Lindor KD, Chalasani N, Raaka S, Heathcote J, Miskovsky E, Shaffer E, Rulyak SJ, Kowdley KV . HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis[J]. Hepatology, 2007,46(3):723-729
doi: 10.1002/(ISSN)1527-3350
[18] Yang JF, Chen ZY, Xiang BK, Yao DG, Yan MX, He BH . Changes of serum leptin in patients with non-alcoholic fatty live[J]. Zhonghua Xiao Hua Za Zhi, 2004,24(12):752-756
杨建锋, 陈芝芸, 项柏康, 姚定国, 严茂祥, 何蓓晖 . 非酒精性脂肪肝患者血清瘦素的变化[J]. 中华消化杂志, 2004,24(12):752-756
[19] Mi XF, Huang ZC, Wang MC, Li SM . Determination of serum iron, transferrin, and ferritin level in nonalcoholic fatty liver patients[J]. Shanghai Yi Yao, 2006,27(11):517-518
弭希峰, 黄子成, 王木成, 李水淼 . 非酒精性脂肪肝患者血清铁、转铁蛋白、血清铁蛋白水平测定[J]. 上海医药, 2006,27(11):517-518
[20] Kohgo Y, Ohtake T, Ikuta K, Suzuki Y, Torimoto Y, Kato J . Dysregulation of systemic iron metabolism in alcoholic liver diseases[J]. J Gastroenterol Hepatol, 2008,23(Suppl 1):S78-S81
doi: 10.1111/j.1440-1746.2007.05290.x
[21] Bonkovsky HL, Lambrecht RW, Shan Y . Iron as a co-morbid factor in nonhemochromatotic liver disease[J]. Alcohol, 2003,30(2):137-144
doi: 10.1016/S0741-8329(03)00127-7
[22] Li Q, Wang XF, Ma XH . Advancement in correlation study on iron overload and insulin resistance[J]. Yi Xue Zong Shu, 2008,14(13):1932-1934
李琪, 王晓峰, 马向华 . 铁超负荷与胰岛素抵抗的相关性研究进展[J]. 医学综述, 2008,14(13):1932-1934
[23] Nakagawa T, Muramoto Y, Hori M, Mihara S, Marubayashi T, Nakagawa K . A preliminary investigation of the association between haptoglobin polymorphism, serum ferritin concentration and fatty liver disease[J]. Clin Chim Acta, 2008,398(1-2):34-38
doi: 10.1016/j.cca.2008.08.004
[24] Trombini P, Piperno A . Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons[J]. J Hepatol, 2007,46(4):549-552
doi: 10.1016/j.jhep.2007.01.004
[25] Xu ZJ, Fan JG, Wang XP, Wang GL . Upregulating expressions of hepatic lipopolysaccharide receptors in nonalcoholic steatohepatitic rats[J]. Zhonghua Gang Zang Bing Za Zhi, 2006,14(1):49-52
徐正捷, 范建高, 王兴鹏, 王国良 . 非酒精性脂肪性肝炎大鼠肝脏内毒素受体表达上调[J]. 中华肝脏病杂志, 2006,14(1):49-52
[26] Huang S, Czech MP . The GLUT4 glucose transporter[J]. Cell Metab, 2007,5(4):237-252
doi: 10.1016/j.cmet.2007.03.006
[27] Harrison SA, Fincke C, Helinski D, Torgerson S, Hayashi P . A pilot study of orlistat treatment in obese non-alcoholic steatohepatitis patients[J]. Aliment Pharmacol Ther, 2004,20(6):623-628
doi: 10.1111/apt.2004.20.issue-6
[28] Rodgers JT, Puigserver P . Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1[J]. Aliment Pharmacol Ther, 2007,104(31):12861-12866
[29] Chen R, Guo Q, Zhu WJ, Xie Q, Wang H, Cai W . Therapeutic efficacy of ω-3 polyunsaturated fatty acid capsule in treatment of patients with non-alcoholic fatty liver disease[J]. Shi Jie Hua Ren Xiao Hua Za Zhi, 2008,16(18):2002-2006
陈榕, 郭清, 朱文静, 谢青, 王晖, 蔡伟 . ω-3多不饱和脂肪酸胶丸对非酒精性脂肪肝患者的治疗作用[J]. 世界华人消化杂志, 2008,16(18):2002-2006
[30] Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, Bedogni G, Svegliati-Baroni G, Sofi F, Milani S, Abbate R, Surrenti C, Casini A . Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study[J]. Aliment Pharmacol Ther, 2006,23(8):1143-1151
doi: 10.1111/apt.2006.23.issue-8
[31] Fan JG . Prevention and treatment of fatty liver by integrative medicine[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2007,27(4):294-295
范建高 . 脂肪肝的中西医结合防治[J]. 中国中西医结合杂志, 2007,27(4):294-295
[32] Wang J, Chen DF . Study progress of the relationship between Sirt1 and non-alcoholic fatty liver disease[J]. Chongqing Yi Xue, 2009,38(4):425-426
王军, 陈东风 . Sirt1与非酒精性脂肪性肝病关系的研究进展[J]. 重庆医学, 2009,38(4):425-426
[33] Yu YQ, Chen HJ . Efficacy observation of prostaglandin E1 in treatment of elderly fatty liver disease[J]. Shi Yong Lao Nian Yi Xue, 2000,14(2):92-93
于艳秋, 陈海江 . 前列腺素E1治疗老年脂肪肝疗效观察[J]. 实用老年医学, 2000,14(2):92-93
[34] Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E . Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality[J]. Ann Intern Med, 2005,142(1):37-46
doi: 10.7326/0003-4819-142-1-200501040-00110
[35] Neuner P, Klosner G, Schauer E, Pourmojib M, Macheiner W, Grunwald C, Knobler R, Schwarz A, Luger TA, Schwarz T . Pentoxifylline in vivo down-regulates the release of IL-1beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells[J]. Immunology, 1994,83(2):262-267
[36] Facchini FS, Hua NW, Stoohs RA . Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease[J]. Gastroenterology, 2002,122(4):931-939
doi: 10.1053/gast.2002.32403
[37] Zheng J . Study on the changes of TG, CHOT, LDL, ALT in serum of fatty liver suffering with intestinal dysbacteriosis[J]. Zhongguo Wei Sheng Tai Xue Za Zhi, 2007,19(2):161-162
郑军 . 肠道菌群失调与脂肪肝患者血脂和丙氨酸氨基转移酶的变化研究[J]. 中国微生态学杂志, 2007,19(2):161-162
[38] Higashiyama R, Inagak Y, Hong YY, Kushida M, Nakao S, Niioka M, Watanabe T, Okano H, Matsuzaki Y, Shiota G, Okazaki I . Bone marrow derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice[J]. Hepatology, 2007,45(1):213-222
doi: 10.1002/(ISSN)1527-3350
[39] Xu XZ, Chen B, Ni Y . Study the effect of transplant with bone marrow mesenchymal stem cells(MSCs) on the rat liver fibrosis model induced by carbon tetrachloride(CCl4)[J]. Zhongguo Re Dai Bing Yi Xue, 2008,8(1):16-18
徐献忠, 陈斌, 倪勇 . 大鼠干细胞移植对四氯化碳所致大鼠肝硬化的影响[J]. 中国热带病医学, 2008,8(1):16-18
[40] Shi JP, Xiang BK, Chen ZY . The role of PPARγ in non-alcoholic fatty liver disease[J]. Yi Xue Yan Jiu Za Zhi, 2006,35(1):57-59
施军平, 项柏康, 陈芝芸 . PPARγ在非酒精性脂肪性肝病中的作用[J]. 医学研究杂志, 2006,35(1):57-59
[41] Di Marzo V, Matias I . Endocannabinoid control of food intake and energy balance[J]. Nat Neurosci, 2005,8(5):585-589
doi: 10.1038/nn1457
[42] Daubioul CA, Horsmans Y, Lambert P, Danse E, Delzenne NM . Effects of oligofructose on glucose and lipid metabolism in patients with non-alcoholic steatohepatitis: results of a pilot study[J]. Eur J Clin Nutr, 2005,59(5):723-726
doi: 10.1038/sj.ejcn.1602127
[43] Ye F, Zhao WX . Research status quo of non-alcoholic fatty liver in traditional Chinese medicine[J]. Zhongguo Zhong Xi Yi Jie He Xiao Hua Za Zhi, 2003,11(1):60-62
叶放, 赵文霞 . 中医对非酒精性脂肪肝的研究现状[J]. 中国中西医结合消化杂志, 2003,11(1):60-62
[44] Chen W, Wu KY . Study progress of fatty live disease in traditional Chinese medicine[J]. Zhong Yi Yao Tong Bao, 2008,7(4):64-66
陈玮, 吴宽裕 . 脂肪肝的中医药研究进展[J]. 中医药通报, 2008,7(4):64-66
[45] Zhang X, Liu Q, Ma GY . Clinical observation of Zhigan Decoction in treatment of 38 cases of fatty liver disease[J]. Zhonghua Ming Yi Lun Tan, 2005,( 1):22-23
张希, 刘清, 马桂英 . 脂肝煎治疗脂肪肝38例临床观察[J]. 中华名医论坛, 2005,( 1):22-23
[46] Chen XY, Zhao H, Shen M, Jiang SH . Effects of Tiaozhisan Capsule in treatment of 46 senile hyperlipidemia cases of fatty liver disease[J]. Shi Yong Zhong Yi Nei Ke Za Zhi, 2003,17(4):311
陈晓云, 赵红, 沈梅, 姜松鹤 . 调脂散胶囊治疗老年高脂血症性脂肪肝46例[J]. 实用中医内科杂志, 2003,17(4):311
[47] Peng LS, He JS, Zhou DQ, Gao H, Zhou XM, Li WX, Tong GD, Chen L . Mechanisms of therapy for invigorating spleen, promoting digestion to remove food retention and promoting blood circulation in prevention and treatment of fatty liver disease in rats[J]. Zhong Yi Yan Jiu, 2006,19(3):17-19
彭立生, 贺劲松, 周大桥, 高辉, 周小梅, 李伟雄, 童光东, 陈亮 . 健脾消导、活血化瘀法对大鼠脂肪肝防治作用的机制研究[J]. 中医研究, 2006,19(3):17-19
[48] Zhang H, Feng Q, Hu YY, Liu CH, Liu P . Prevention and treatment of “Qushi Huayu Decoction” on fatty liver of rats induced by carbon tetrachloride along with high-fat and low-protein diet[J]. Shanghai Zhong Yi Yao Za Zhi, 2006,40(3):52-55
张慧, 冯琴, 胡义扬, 刘成海, 刘平 . 祛湿化瘀方对CCl4复合高脂低蛋白饮食诱导的大鼠脂肪肝的防治作用[J]. 上海中医药杂志, 2006,40(3):52-55
[49] Chen GF, Cheng Y, Zhou Y, Shen L, Xu LM . Intervening effect of Danze Jiangzhi decoction(DZJZ) on the non-alcoholic fatty liver disease in rats[J]. Zhong Xi Yi Jie He Gan Bing Za Zhi, 2007,17(4):214-216
陈高峰, 成扬, 周扬, 沈丽, 徐列明 . 丹泽降脂方防治大鼠非酒精性脂肪肝的实验研究[J]. 中西医结合肝病杂志, 2007,17(4):214-216
[50] Feng R . Clinical observation of Huoxue Jiangzhi Tiaogan Decoction in treatment of 39 cases of fatty liver disease[J]. Sichuang Zhong Yi, 2006,24(12):61-62
冯蓉 . 活血降脂调肝汤治疗脂肪肝39例临床观察[J]. 四川中医, 2006,24(12):61-62
[51] Cheng LB, Zhang CZ . Jiangzhi Yigan Decoction in treatment of 32 cases of fatty liver disease[J]. Zhong Xi Yi Jie He Gan Bing Za Zhi, 2005,15(3):179-180
程良斌, 张赤志 . 降脂益肝汤治疗脂肪肝32例[J]. 中西医结合肝病杂志, 2005,15(3):179-180
[52] Huang DY, Yao DP, Zhu ZY . Clinical observation of Huzhang Jiangzhi Decoction and auricular pressing in treatment of 80 cases of fatty liver disease[J]. Jiangsu Zhong Yi Yao, 2008,40(4):44-45
黄德亚, 姚东坡, 朱志义 . “虎杖降脂汤”内服结合耳穴按压法治疗脂肪肝80例临床观察[J]. 江苏中医药, 2008,40(4):44-45
[53] Ming YH . Medicine-separated moxibustion cake combined with drugs in treatment of 81 cases of simple non-alcoholic fatty liver[J]. Zhong Xi Yi Jie He Gan Bing Za Zhi, 2008,18(3):172-173
明玉华 . 隔药饼灸联合药物治疗非酒精性单纯性脂肪肝81例[J]. 中西医结合肝病杂志, 2008,18(3):172-173
[54] Wang J, Zhang CY, Cheng L, Chen LQ . Clinical observation of electro-acupuncture plus ear-acupuncture in treating 30 cases of obese fatty liver[J]. Shanghai Zhong Yi Yao Za Zhi, 2006,40(7):41-42
王骏, 张春燕, 程玲, 陈利群 . 健脾法电针配合耳穴治疗肥胖性脂肪肝30例临床观察[J]. 上海中医药杂志, 2006,40(7):41-42
[55] Liu YP, Liu SS, Ma XQ . Clinical observation of Xiaozhi Decoction with acupuncture in treatment of 90 cases of fatty liver[J]. Zhen Jiu Lin Chuang Za Zhi, 2007,23(2):9-10
刘亚平, 刘树山, 马秀琴 . 消脂汤配合针灸治疗脂肪肝90例的临床观察[J]. 针灸临床杂志, 2007,23(2):9-10
[56] Jin JJ, Xu YL, Zheng Y . Effects of acupoint-injection of Kaixilai on TG, TC, MDA, SOD, AST and ALT in the patient of non-alcoholic fatty liver[J]. Zhongguo Zhen Jiu, 2006,26(2):100-102
金建军, 徐亚莉, 郑昱 . 穴位注射对非酒精性脂肪肝血脂代谢及肝功能的影响[J]. 中国针灸, 2006,26(2):100-102
[57] Zhou L, Lin GQ, Pang CX, Pang Y . Observation of the therapeutic effects on fatty liver by acupuncture combined with intravenous drip of Xueshuantong injection[J]. Hebei Zhong Yi, 2008,30(9):961-962
周丽, 林桂权, 庞崇祥, 庞燕 . 针刺配合血栓通注射液治疗脂肪肝疗效观察[J]. 河北中医, 2008,30(9):961-962
[58] Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, Paolis D, Capussotti L, Salizzoni M, Rizzetto M . Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma[J]. Gastroenterology, 2002,123(1):134-140
doi: 10.1053/gast.2002.34168
[59] Uraz S, Aygun C, Sonsuz A, Ozbay G . Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis[J]. Dig Dis Sci, 2005,50(5):964-969
doi: 10.1007/s10620-005-2672-z
[1] Arthur Yin Fan, Hui Ouyang, Xinru Qian, Hui Wei, David Dehui Wang, Deguang He, Haihe Tian, Changzhen Gong, Amy Matecki, Sarah Faggert Alemi. Discussions on real-world acupuncture treatments for chronic low-back pain in older adults. Journal of Integrative Medicine, 2019, 17(2): 71-76.
[2] Bruno José Martins Da Silva, Amanda Anastácia Pinto Hage, Edilene Oliveira Silva, Ana Paula Drummond Rodrigues. Medicinal plants from the Brazilian Amazonian region and their antileishmanial activity: A review. Journal of Integrative Medicine, 2018, 16(4): 211-222.
[3] Yoshiharu Motoo, Takashi Hakamatsuka, Nobuo Kawahara, Ichiro Arai, Kiichiro Tsutani. Standards of Reporting Kampo Products (STORK) in research articles. Journal of Integrative Medicine, 2017, 15(3): 182-185.
[4] Qing Ji, Yun-quan Luo, Wen-hai Wang, Xuan Liu, Qi Li, Shi-bing Su. Research advances in traditional Chinese medicine syndromes in cancer patients. Journal of Integrative Medicine, 2016, 14(1): 12-21.
[5] Nobuari Takakura, Miho Takayama, Hiroyoshi Yajima. The difference of park and streitberger single-blind needles from takakura double-blind needle. Journal of Integrative Medicine, 2015, 13(4): 212-214.
[6] Chang-quan Ling​, Xiao-qiang Yue, Chen Ling​. Three advantages of using traditional Chinese medicine to prevent and treat tumor. Journal of Integrative Medicine, 2014, 12(4): 331-335.
[7] Feng-bin Liu, Zheng-kun Hou, Yun-ying Yang, Pei-wu Li, Qian-wen Li, Nelson Xie, Jing-wei Li, Xiang-jing Zeng. Literature review and analysis of the application of health outcome assessment instruments in Chinese medicine. Journal of Chinese Integrative Medicine, 2013, 11(3): 157-167.
[8] Jian-sheng Li, Ya Li, Su-yun Li, Yuan-yuan Wang, Li Deng, Yan-ge Tian, Su-li Jiang , Ying Wang. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease. Journal of Chinese Integrative Medicine, 2012, 10(9): 1039-1048.
[9] Zhao-lan Liu, Qing Li , Yu-jie Mu , Ying Gao, Jian-ping Liu. Using nested case-control study to appraise the effectiveness of Chinese medicines in the treatment of diabetic nephropathy. Journal of Chinese Integrative Medicine, 2012, 10(9): 991-996.
[10] Zhang-ling Zhou, Cheng-xin Li, Yue-bo Jiang, Cong Zuo, Yun Cai, Rui Wang. Correlation between facial nerve functional evaluation and efficacy evaluation of acupuncture treatment for Bell’s palsy. Journal of Chinese Integrative Medicine, 2012, 10(9): 997-1002.
[11] Wei-hua Xu, Ze-huai Wen, Wei-xiong Liang, Qi Wang. A review of research on the development of instruments for therapeutic efficacy evaluation of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(7): 726-737.
[12] Ming-xing Zhao, Zhen-hua Dong, Zhong-hai Yu, Shi-yuan Xiao, Ya-ming Li . Effects of Ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 628-634.
[13] Li-xin Ma, Yu-yi Wang, Xin-xue Li, Jian-ping Liu . Systematic review on methodology of randomized controlled trials of post-marketing Chinese patent drugs for treatment of type 2 diabetes. Journal of Chinese Integrative Medicine, 2012, 10(3): 279-292.
[14] Yan-bo Zhu , Hideki Origasa, Xiao-xia Luo, Yang-yang Wang , Jie Di , Lin Lin. Responsiveness of three subjective report of outcome measures for chronic heart failure. Journal of Chinese Integrative Medicine, 2012, 10(12): 1375-1381.
[15] Sui Yue Hu, Su E Wang, Chun Hu Zhang. Relationship between symptom stratification and syndrome differentiation of traditional Chinese medicine for depressive episode. Journal of Chinese Integrative Medicine, 2011, 9(9): 933-936.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[3] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[4] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[7] Chan Chen, Yong-mei Meng , Peng Zhang, Juan Wang, Hui-hui Zhao, Shu-zhen Guo , Wei Wang. Diagnosis and treatment rule of traditional Chinese medicine for syndrome factors of chronic congestive heart failure: a study based on Shannon entropy method. Journal of Chinese Integrative Medicine, 2010, 8(11): 1080-1084
[8] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[9] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239
[10] Ming-qing Wei , Jin-zhou Tian , Jing Shi , Fu-yun Ma , Ying-chun Miao , Yong-yan Wang. Effects of Chinese medicine for promoting blood circulation and removing blood stasis in treating patients with mild to moderate vascular dementia: a randomized, double-blind and parallel-controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(11): 1240-1246